Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Key patents related to its CpG-based products licensed by Coley from Isis

Oct. 13, 2000

Immunosuppressant ISAtx-247 moves steadily through clinical trials

Oct. 13, 2000

Macrolide immunomodulators in the Abbott pipeline

Oct. 11, 2000

Vaccine for preventing UTIs in early clinical trials at MedImmune

Oct. 11, 2000

RSV subunit vaccine successfully proceeds through clinical trials

Oct. 11, 2000

Grant awarded to Cel-Sci for herpes simplex vaccine development

Oct. 11, 2000

NIAID awards grants for drug and vaccine development

Oct. 10, 2000

AstraZeneca presents new tyrosine kinase inhibitors with immunomodulating activity

Oct. 9, 2000

BioSante's CAP vaccine adjuvant completes phase I clinical trial

Oct. 6, 2000

Preclinical studies indicate potential for ISAtx-247 in diabetes treatment

Oct. 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.